Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2026-03-01 @ 12:34 PM
Study NCT ID:
NCT02400333
Status:
COMPLETED
Last Update Posted:
2016-09-29
First Post:
2015-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06
Start Date Type:
None
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-09
First Submit QC Date:
None
Study First Post Date:
2015-03-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-05-18
Results First Submit QC Date:
None
Results First Post Date:
2016-08-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-08-16
Last Update Post Date:
2016-09-29
Last Update Post Date Type:
ESTIMATED